SUVEXX Recall: Assay Out of Specification
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Health Canada has issued a recall for SUVEXX tablets due to an out-of-specification assay in a specific lot, affecting product quality.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on April 20, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, HealthProduct.
What Happened
The assay is out of specification in the affected lot, as announced by Health Canada.
Which Products Are Affected
The affected product is SUVEXX with Market Authorization DIN 02496305, a tablet dosage form containing Sumatriptan 85mg and Naproxen sodium 500mg, and lot number 0000159323. No quantities, UPCs, model numbers, date ranges, or specific regions beyond the recall depth of retailers are specified.
What You Should Do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects or other safety complaints to Health Canada.
Why This Matters
This recall ensures the quality and safety of the affected health product, potentially impacting consumers who rely on it for treatment.
Source
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,042 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 20, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.